BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22865299)

  • 1. Shorter peripheral blood telomeres are a potential biomarker for patients with advanced colorectal adenomas.
    Riegert-Johnson DL; Boardman LA; Crook JE; Thomas CS; Johnson RA; Roberts ME
    Int J Biol Markers; 2012 Dec; 27(4):e375-80. PubMed ID: 22865299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length in the colon is related to colorectal adenoma prevalence.
    Peacock SD; Massey TE; Vanner SJ; King WD
    PLoS One; 2018; 13(10):e0205697. PubMed ID: 30332457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer.
    Maxwell F; McGlynn LM; Muir HC; Talwar D; Benzeval M; Robertson T; Roxburgh CS; McMillan DC; Horgan PG; Shiels PG
    Clin Cancer Res; 2011 Sep; 17(17):5573-81. PubMed ID: 21753158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.
    De Chiara L; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Cordero OJ; Martínez-Ares D; Páez de la Cadena M
    BMC Cancer; 2010 Jun; 10():333. PubMed ID: 20584285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte telomere length throughout the continuum of colorectal carcinogenesis.
    Zöchmeister C; Brezina S; Hofer P; Baierl A; Bergmann MM; Bachleitner-Hofmann T; Karner-Hanusch J; Stift A; Gerger A; Leeb G; Mach K; Rachakonda S; Kumar R; Gsur A
    Oncotarget; 2018 Mar; 9(17):13582-13592. PubMed ID: 29568379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study.
    Moravkova P; Kohoutova D; Vavrova J; Bures J
    Scand J Clin Lab Invest; 2020 May; 80(3):173-178. PubMed ID: 31856598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
    LaPointe LC; Pedersen SK; Dunne R; Brown GS; Pimlott L; Gaur S; McEvoy A; Thomas M; Wattchow D; Molloy PL; Young GP
    PLoS One; 2012; 7(1):e29059. PubMed ID: 22276102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of advanced adenomas on index colonoscopy: Important risk factor for metachronous advanced colorectal neoplasia.
    Park SK; Yang HJ; Jung YS; Park JH; Sohn CI; Park DI
    Dig Liver Dis; 2018 Jun; 50(6):568-572. PubMed ID: 29588111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.
    Tuohy TM; Rowe KG; Mineau GP; Pimentel R; Burt RW; Samadder NJ
    Cancer; 2014 Jan; 120(1):35-42. PubMed ID: 24150925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length differences between colorectal polyp subtypes: a colonoscopy-based case-control study.
    Hardikar S; Burnett-Hartman AN; Phipps AI; Upton MP; Zhu LC; Newcomb PA
    BMC Cancer; 2018 May; 18(1):513. PubMed ID: 29720120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
    Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
    Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of advanced colorectal neoplasm by the proposed combined United States and United Kingdom risk stratification guidelines.
    Park SK; Yang HJ; Jung YS; Park JH; Sohn CI; Park DI
    Gastrointest Endosc; 2018 Mar; 87(3):800-808. PubMed ID: 28986265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adenomas and advanced adenomas in patients in the 40- to 49-year age group undergoing screening colonoscopy because of a family history of adenoma/polyp in a first-degree relative.
    Gupta A; Samadder J; Elliott E; Sethi S; Schoenfeld P
    Gastrointest Endosc; 2012 Apr; 75(4):705-11. PubMed ID: 22440200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.
    Mzahma R; Kharrat M; Fetiriche F; Bouasker ; Ben Moussa M; Ben Safta Z; Dziri C; Zaouche A; Chaabouni-Bouhamed H
    Tumour Biol; 2015 Nov; 36(11):8703-13. PubMed ID: 26047604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.